- Home
- RPRX
RPRX
Royalty Pharma plc
as 01-23-2025 4:00pm EST
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
| Founded: | 1996 | Country: | United States |
| Employees: | 89 | City: | NEW YORK |
| Market Cap: | 13.6B | IPO Year: | 2020 |
| Target Price: | $41.67 | AVG Volume (30 days): | 3.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 2.55 | EPS Growth: | 518.56 |
| 52 Week Low/High: | $24.05 - $31.66 | Next Earning Date: | 02-13-2025 |
| Revenue: | $2,266,003,000 | Revenue Growth: | -2.51% |
| Revenue Growth (this year): | 14.54% | Revenue Growth (next year): | 10.94% |
Latest Royalty Pharma plc News
RPRX Breaking Stock News: Dive into RPRX Ticker-Specific Updates for Smart Investing
Insider Monkey
a day ago
Why Is Andreas Halvorsen Bullish On Royalty Pharma plc (RPRX) Now?
Insider Monkey
9 days ago
Royalty Pharma plc (RPRX): Analysts Recommend This 52-Week High Stocks Now
Simply Wall St.
11 days ago
Royalty Pharma (NASDAQ:RPRX) Has Announced That It Will Be Increasing Its Dividend To $0.22
Insider Monkey
12 days ago
Here’s Why Royalty Pharma plc (RPRX) Led This Week’s Rally
Insider Monkey
13 days ago
Did Royalty Pharma (RPRX) Close Shortened Trading Week Higher?
GlobeNewswire
14 days ago
Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire
14 days ago
Royalty Pharma Announces Transformative Step in Company’s Evolution With Acquisition of its External Manager and $3 Billion Share Repurchase Program
GlobeNewswire
15 days ago
Royalty Pharma Announces Dividend Increase
Compare RPRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RPRX Royalty Pharma plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.